Science and Research

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation

BACKGROUND: There is a need for non-invasive parameters that are sensitive to the development of the bronchiolitis obliterans syndrome (BOS) in lung transplantation (LTx) patients. We studied whether the pulmonary diffusing capacity for inhaled nitric oxide is capable of detecting BOS stages. METHODS: Sixty-one LTx patients were included into this cross-sectional study (19/29/7/3/3 in BOS stages 0/0-p/1/2/3). For analysis stages 0/0-p versus 1/2/3 ("BOS binary-early"), and stages 0/0-p/1 versus 2/3 ("BOS binary-late") were summarized. Measurements of the combined diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) were compared with spirometry and bodyplethysmography, and their relative importance was evaluated by discriminant analysis. RESULTS: Regarding the recognition of "BOS binary-early", among spirometric parameters forced expiratory volume in 1 s (FEV1) was best, among bodyplethysmographic parameters airway resistance, and among diffusing parameters DLNO. Regarding "BOS binary-late", DLNO was inferior to bodyplethysmographic parameters. CONCLUSION: Although the study comprised only measurements at a single time point and no follow-up, DLNO outperformed FEV1, the time course of which is used in detecting BOS. Together with its pathophysiological plausibility, this result suggests that the measurement of DLNO, possibly over time, could be an easily applicable tool for the monitoring of LTx patients and should be evaluated in larger studies.

  • Winkler, A.
  • Kahnert, K.
  • Behr, J.
  • Neurohr, C.
  • Kneidinger, N.
  • Hatz, R.
  • Dressel, H.
  • Radtke, T.
  • Jorres, R. A.

Keywords

  • Bronchiolitis obliterans syndrome
  • Diffusing capacity
  • Lung transplantation
Publication details
DOI: 10.1186/s12931-018-0881-1
Journal: Respiratory research
Pages: 171 
Number: 1
Work Type: Original
Location: CPC-M
Disease Area: ROR
Partner / Member: LMU
Access-Number: 30200966
See publication on PubMed

DZL Engagements

chevron-down